Prices are updated after-hours

TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVJF | News | $12.37 -24.22% 380

(0.0% 1d) (0.0% 1m) (48.1% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (83.09% volume)
Earnings Calendar:
Market Cap: $ 14,739,472,016
http://www.teva.co.il
Sec Filling | Patents | n/a employees

(IL) Teva Pharmaceutical Industries Ltd. engages in the development and production of medicines. Its products include medicines for cardiovascular diseases, pain relievers, obesity, cancer and supportive care, infectious diseases and human immunodeficiency viruses, and colds and coughs. The company was founded in 1901 and is headquartered in Petah Tikva, Israel.

cancer infectious disease pain relief israel cardiovascular

add to watch list Paper trade email alert is off

MorphoSys AG

MPSYF | News | $70.28 -71.33% 110

Health Technology

(0.0% 1d) (0.0% 1m) (154.6% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (223918.67% volume)
Earnings Calendar:
Market Cap: $ 2,583,142,384
http://www.morphosys.de
Sec Filling | Patents | n/a employees

(DE) MorphoSys AG engages in the development of antibodies for therapeutic, diagnostics, and research applications. It operates through the Proprietary Development and Partnered Discovery segments. The Proprietary Development segment combines proprietary research and development of therapeutic compounds. The Partnered Discovery segment offers technologies to make human antibody-based therapeutics on behalf of partners in the pharmaceutical industry. The company was founded by Andreas Pluckthun and Simon E. Moroney in July 1992 and is headquartered in Planegg, Germany.

diagnostics antibody

add to watch list Paper trade email alert is off

Walmart Inc.

WMT | News | $59.09 -1.75% -0.02% 18M

Retail Trade

(0.0% 1d) (-0.7% 1m) (-60.6% 1y) (0.0% 2d) (0.0% 3d) (0.8% 7d) (Infinity% volume)
Earnings Calendar: 2023-05-18
Market Cap: $ 475,674,500,000
http://corporate.walmart.com
Sec Filling | Patents | 2200000 employees

Walmart, Inc. engages in retail and wholesale business. The Company offers an assortment of merchandise and services at everyday low prices. It operates through the following business segments: Walmart U.S., Walmart International, and Sam's Club. The Walmart U.S. segment operates as a merchandiser of consumer products, operating under the Walmart, Wal-Mart, and Walmart Neighborhood Market brands, as well as walmart.com and other eCommerce brands. The Walmart International segment manages supercenters, supermarkets, hypermarkets, warehouse clubs, and cash & carry outside of the United States. The Sam's Club segment comprises membership-only warehouse clubs and samsclubs.com. The company was founded by Samuel Moore Walton and James Lawrence Walton in 1945 and is headquartered in Bentonville, AR.

brands nash msa

Drugs

4X Medicated Toothache and Gum Gel (Benzocaine)
All Day Pain Relief (Naproxen Sodium)
Allergy Relief Dye-Free (Diphenhydramine HCl)
Assorted Fruit Antacid Flavor Chews (Calcium Carbonate)
Berry Throat Drop (Pectin)
Budesonide (Budesonide)
equate (Benzalkonium Chloride)
equate allergy relief (fexofenadine hydrochloride)
Equate Antibacterial Citrus Hand Wipes (Benzalkonium Chloride)
Equate Antibacterial Fresh Hand Wipes (Benzalkonium Chloride)
Equate Antibiotic Plus Pain Relief (Neomycin sulfate, Polymyxin B Sulfate, and Pramoxine Hydrochloride)
Equate Arnica Pain Relieving (ARNICA MONTANA WHOLE)
Equate Beauty Daily Moisturizer SPF-30 Sunscreen (Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone)
Equate Cherry Lip Balm (Petrolatum)
Equate Cherry Zinc Cold Relief Lozenges (Zincum Gluconicum)
Equate Cool and Heat Pain Relieving Liquid (Cool and Heat Pain Relief)
Equate cool mist Antiperspirant (Aluminum Chlorohydrate)
Equate Cucumber Antiperspirant (Aluminum Chlorohydrate)
Equate Effervescent Antacid and Pain Relief (Aspirin, Citric Acid, Sodium Bicarbonate)
Equate Effervescent Cold Relief (Aspirin, Chlorpheniramine Maleate, Phenylephrine Bitartrate)
Equate Maximum Strength Urinary Pain Relief (PHENAZOPYRIDINE HYDROCHLORIDE)
Equate Moisture SPF 15 Lip Balm (Oxybenzone, Octinoxate, Petrolatum)
Equate Ready-to-Use Enema Laxative (SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM and SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM)
Equate Redness Reliever (tetrahydrozoline hydrochloride)
Equate Restore Dual Lubricating (Carboxymethylcellulose Sodium, and Glycerin)
Equate Restore Plus Lubricant Eye Drops (carboxymethylcellulose sodium)
Equate Sore Throat Pops (Pectin)
Equate Sunscreen Mineral Broadspectrum SPF 50 BABY ZINC (Zinc Oxide)
Equate SUNSCREEN spf 50 SPORT broadspectrum (Avobenzone,Homosalate,Octisalate,Octocrylene)
EXTRA STRENGTH PAIN RELIEVER PM (ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE)
Fluticasone Propionate (Fluticasone Propionate)
Herbal Cough Drops (Menthol)
Honey Cough Drops (Menthol)
Jock Itch Clotrimazole Antifungal (Clotrimazole)
Pain Reliever PM (Acetaminophen, Diphenhydramine HCl)
Simethicone (Simethicone)
Sleep Aid Nighttime (Diphenhydramine HCl)
Stool Softener Laxative (Docusate sodium, Sennosides)
Sugar Free Honey Lemon Cough Drops (Menthol)
Sunburn Relief (Lidocaine HCl 0.5%)
Vegetable Laxative (Sennosides)

add to watch list Paper trade email alert is off

XOMA Corporation

XOMA | $26.15 1.28% 1.26% 12K

Health Technology

(0.0% 1d) (7.6% 1m) (42.2% 1y) (0.0% 2d) (0.0% 3d) (6.5% 7d) (-57.96% volume)
Earnings Calendar: 2024-03-07
Market Cap: $ 304,255,642
http://www.xoma.com
Sec Filling | Patents | 10 employees

(US) XOMA Corp. engages in the discovery and development of therapeutics derived from platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. The company was founded by Patrick J. Scannon in 1981 and is headquartered in Emeryville, CA.

antibody

add to watch list Paper trade email alert is off

BlackRock, Inc.

BLK | $766.62 0.86% 0.0% 460K

Finance

(0.0% 1d) (-6.9% 1m) (12.7% 1y) (0.0% 2d) (0.0% 3d) (0.4% 7d) (-28.89% volume)
Earnings Calendar: 2024-01-12
Market Cap: $ 114,033,575,837
http://www.blackrock.com
Sec Filling | Patents | 16200 employees

(US) BlackRock, Inc. engages in providing investment management, risk management, and advisory services for institutional and retail clients worldwide. Its products include single and multi-asset class portfolios investing in equities, fixed income, alternatives, and money market instruments. The company was founded by Ralph L. Schlosstein, Susan L. Wagner, Robert Steven Kapito, and Laurence Douglas Fink in 1988 and is headquartered in New York, NY.

glass

add to watch list Paper trade email alert is off

Anavex Life Sciences Corp.

AVXL | $3.68 0.0% 1.4M

Health Technology

(0.0% 1d) (-19.1% 1m) (-53.1% 1y) (0.0% 2d) (0.0% 3d) (-9.6% 7d) (-34.81% volume)
Earnings Calendar: 2024-02-06
Market Cap: $ 302,174,040
http://www.anavex.com
Sec Filling | Patents | 16 employees

(US) Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.

neurodegenerative alzheimer nervous system parkinson treatment alzheimer’s

add to watch list Paper trade email alert is off

X Financial

XYF | News | $3.882 -0.46% 0.0% 340

Finance

(0.0% 1d) (-17.7% 1m) (23.4% 1y) (0.0% 2d) (0.0% 3d) (1.6% 7d) (-100.0% volume)
Earnings Calendar:
Market Cap: $ 123,771,460
http://www.xiaoyinggroup.com
Sec Filling | Patents | 693 employees

X Financial engages in the development and provision of technology platform for personal finance services. The company was founded by Yue Tang on January 5, 2015 and is headquartered in Shenzhen, China.

china

add to watch list Paper trade email alert is off

Chemours Company (The)

CC | $26.73 1.14% 0.0% 1.1M

Process Industries

(0.0% 1d) (-6.8% 1m) (-8.6% 1y) (0.0% 2d) (0.0% 3d) (-1.1% 7d) (Infinity% volume)
Earnings Calendar: 2024-04-08
Market Cap: $ 3,979,587,794
http://www.chemours.com
Sec Filling | Patents | 7000 employees

(US) The Chemours Co. is a holding company, which engages in the provision of performance chemicals. It operates through the following segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Titanium Technologies segment produces titanium dioxide. The Fluoroproducts segment supplies refrigerants and industrial fluoropolymer resins. The Chemical Solutions segment provides chemicals used in gold production, oil refining, agriculture, and industrial polymers. The firm offers refrigerants, industrial fluoropolymer resins, sodium cyanide, performance chemicals and intermediates, and titanium dioxide pigments to the plastics and coatings, refrigeration and air conditioning, general industrial, electronics, mining, and oil refining markets. The company was founded on February 18, 2014 and is headquartered in Wilmington, Delaware.

electronics agricultural refrigerants refrigerant agriculture mining

add to watch list Paper trade email alert is off

Checkpoint Therapeutics, Inc.

CKPT | $1.43 -1.38% -1.4% 350K

Health Technology

(0.0% 1d) (-27.5% 1m) (-52.9% 1y) (0.0% 2d) (0.0% 3d) (-0.7% 7d) (-100.0% volume)
Earnings Calendar: 2022-11-03
Market Cap: $ 50,030,379
http://www.checkpointtx.com
Sec Filling | Patents | 8 employees

(US) Checkpoint Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. Its product portfolio include CK-301, CK-101, CK-103, and CK-302. The company was founded on November 10, 2014 and is headquartered in New York, NY.

acquisitions cancer treatment

add to watch list Paper trade email alert is off

Rallybio Corp

RLYB | News | $1.84 3.96% 3.8% 240K

(0.0% 1d) (18.0% 1m) (-63.7% 1y) (0.0% 2d) (0.0% 3d) (2.9% 7d) (-100.0% volume)
Earnings Calendar: 2024-03-04
Market Cap: $ 69,574,025
https://rallybio.com
Sec Filling | Patents | 2021 employees

Rallybio is a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases. Since its launch in January 2018, Rallybio has built a portfolio of promising product candidates, which are now in development to address rare diseases in the areas of hematology, immuno-inflammation, maternal fetal health and metabolic disorders. The Company’s mission is being advanced by a team of highly experienced biopharma industry leaders with extensive research, development, and rare disease expertise. Rallybio is headquartered in New Haven, Connecticut, with an additional facility at the University of Connecticut’s Technology Incubation Program in Farmington, Connecticut.

urea metabolic

add to watch list Paper trade email alert is off

Stellantis N.V

STLA | $24.96 1.55% -0.02% 5.4M

Manufacturing

(0.0% 1d) (-16.4% 1m) (49.7% 1y) (0.0% 2d) (0.0% 3d) (-4.7% 7d) (1.63% volume)
Earnings Calendar:
Market Cap: $ 38,703,414,372
https://www.fcagroup.com/
Sec Filling | Patents | 204000 employees

(United Kingdom) Stellantis is one of the world's leading automakers and a mobility provider, guided by a clear vision: to offer freedom of movement with distinctive, affordable and reliable mobility solutions. In addition to the Group's rich heritage and broad geographic presence, its greatest strengths lie in its sustainable performance, depth of experience and the wide-ranging talents of employees working around the globe. Stellantis will leverage its broad and iconic brand portfolio, which was founded by visionaries who infused the marques with passion and a competitive spirit that speaks to employees and customers alike. Stellantis aspires to become the greatest, not the biggest while creating added value for all stakeholders as well as the communities in which it operates.

dividends!

add to watch list Paper trade email alert is off

KONINKLIJKE PHILIPS NV

RYLPF | $20.52 3.85% 110K

Health Technology

(0.0% 1d) (3.4% 1m) (-5.7% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (1538.38% volume)
Earnings Calendar:
Market Cap: $ 18,827,564,060
http://www.philips.com
Sec Filling | Patents | n/a employees

(NL) Royal Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Personal Health, Diagnosis & Treatment, Connected Care & Health Informatics, and Other. The Personal Health segment focuses on healthy living and preventative care. This segment comprises the Personal Care, Domestic Appliances, Oral Healthcare, and Mother & Child Care businesses. The Diagnosis & Treatment segment unites the businesses related to the promise of precision diagnosis and disease pathway selection, and the businesses related to image-guided, minimally invasive treatments. This segment comprises the Diagnostic Imaging, Ultrasound, Healthcare Informatics and Image-Guided Therapy businesses. The Connected Care & Health Informatics segment focuses on patient care solutions, advanced analytics and patient and workflow optimization inside and outside the hospital, and aims to unlock synergies from integrating and optimizing patient care pathways and leveraging provider-payer-patient business models. This segment comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, and Sleep & Respiratory Care businesses. The Other segment reports on the items Innovation & Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

diagnostics respiratory treatment optical

add to watch list Paper trade email alert is off

MorphoSys AG

MOR | News | $18.04 0.45% 0.44% 180K

Health Technology

(0.0% 1d) (-1.0% 1m) (233.4% 1y) (0.0% 2d) (0.0% 3d) (-0.4% 7d) (NaN% volume)
Earnings Calendar:
Market Cap: $ 2,717,194,686
http://www.morphosys.de
Sec Filling | Patents | 426 employees

MorphoSys AG engages in the development of antibodies for therapeutic, diagnostics, and research applications. It operates through the Proprietary Development and Partnered Discovery segments. The Proprietary Development segment combines proprietary research and development of therapeutic compounds. The Partnered Discovery segment offers technologies to make human antibody-based therapeutics on behalf of partners in the pharmaceutical industry. The company was founded by Andreas Pluckthun and Simon E. Moroney in July 1992 and is headquartered in Planegg, Germany.

antibody diagnostics brain amyloid alzheimer gantenerumab igg1 antibody

add to watch list Paper trade email alert is off

Huntington Bancshares Incorporated

HBAN F | $13.645 0.85% 0.84% 17M

Finance

(0.0% 1d) (1.2% 1m) (20.8% 1y) (0.0% 2d) (0.0% 3d) (2.9% 7d) (-42.68% volume)
Earnings Calendar: 2024-01-19
Market Cap: $ 19,785,250,000
http://www.huntington.com
Sec Filling | Patents | n/a employees

Huntington Bancshares, Inc. operates as a bank holding company. It provides commercial and consumer banking services, mortgage banking services, automobile financing, recreational vehicle and marine financing, equipment leasing, investment management, trust services, brokerage services, insurance programs, and other financial products and services. The company operates through the following segments: Consumer & Business Banking, Commercial Banking, Commercial Real Estate & Vehicle Finance, Regional Banking & The Huntington Private Client Group, and Home Lending. The Consumer & Business Banking segment provides financial products and services to consumer and small business customers including but not limited to checking accounts, savings accounts, money market accounts, certificates of deposit, investments, consumer loans, credit cards and small business loans. The Commercial Banking segment provides products and services to the middle market, large corporate, and government public sector customers located primarily within its geographic footprint. The segment is divided into following business units: Middle Market, Large Corporate, Specialty Banking, Asset Finance, Capital Markets, Treasury Management, and Insurance. The Commercial Real Estate & Vehicle Finance segment provides products and services include providing financing for land, buildings, and other commercial real estate owned or constructed by real estate developers, automobile dealerships, or other customers with real estate project financing needs, and financing for the purchase of automobiles, light-duty trucks, recreational vehicles and marine craft at franchised dealerships, financing the acquisition of new and used vehicle inventory of franchised automotive dealerships. The Regional Banking and The Huntington Private Client Group segment consists of private banking, wealth & investment management, and retirement plan services. The Home Lending segment originates and services consumer loans and mortgages for customers who are located in primary banking markets. Huntington Bancshares was founded in 1966 and is headquartered in Columbus, OH.

acquisitions vehicles insurance automobile marine automotive msa construction

add to watch list Paper trade email alert is off